Parathyroidhormon (1) – Preotact®
Osteoporosis (postmenopausal)
Characteristics
| Start date | 15.10.2013 |
|---|---|
| Resolution | 14.11.2013 |
| INN | Parathyroidhormon |
| Brand name | Preotact® |
| Pharm. company | Takeda GmbH |
| G-BA Procedure ID | D-083 |
| ATC code | H05AA03 Parathyroid hormones and analogues (H05AA) |
| DDD | 0.1 mg P |
| Therapeutic area | Musculoskeletal system diseases Osteoporosis |
| Reason for procedure | not completed: discontinued |
Associated procedures
<< List of all resolutions